NCI Partners with Seoul University on Clinical Proteomics | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck an agreement with a South Korean hospital to partner on the development and application of proteomic tools in a clinical environment.

NCI's Office of Cancer Clinical Proteomics Research (OCCPR) and Seoul National University Cancer Hospital (SNUCH) have inked a memorandum of understanding under which SNUCH will test proteomic technologies, standards, workflows, and protein assays developed by NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.